Product Images Venlafaxine Hydrochloride

This is a pack of 10 capsules of Venlafaxine Hydrochloride Extended-Release Capsules, USP with each capsule containing 75mg of Venlafaxine Hydrochloride, meant for adult use only. The drug should be stored at 20°C to 25°C and should be kept out of reach from children. RX Only. It is distributed by Major Pharmaceuticals, located in Michigan, USA through their distributor, Cardinal Health located in Dublin, Ohio. The manufacturer of the drug is Cadila Healthcare Ltd located in Ahmedabad, India. The pack should be dispensed along with a medication guide that can be found at www.majorpharmaceuticals.com. The complete prescribing information, precautions, and warnings can also be found in the product insert. The package is not child resistant and is intended for institutional use only.*

This is a drug interaction table that lists different drugs and how they interact in patients with different metabolic profiles (CYP2D6 EM's and PM's). The table provides PK (pharmacokinetic) fold change and a recommendation, including avoiding concomitant use or using with caution in patients with certain conditions. The table also indicates the clinical significance or unknown effects of the interaction. The table appears to include information on the drug venlafaxine and some PK numeric values under Cmax, Auc, and AuC.*

This appears to be a list of various drugs and their potential interactions, as well as recommendations for use based on changes to PKFold and 90% C values. It includes information on a range of drugs, including Diazepam, Alprazolam, Lithium, and more. The text provides guidelines for use, including dose adjustments, avoidance of concomitant use, and monitoring of blood pressure, where necessary.*

This appears to be a table containing recommendations for the dosage adjustment of the analyte Venlafaxine in individuals with different characteristics such as hepatic or renal impairment, CYP2D8 polymorphism, age, and gender. The table illustrates fold change and 90% confidence intervals and indicates whether a dose adjustment is necessary or not for each specific case. However, the format of the text is difficult to decipher due to multiple misspellings and lack of context.*

The text contains two different pieces of information, but they don't seem to be related to each other. "eHCI H4C0 C" is not a recognizable text and seems to be an error obtained by the system. "venlafaxine hydrochloride" is a pharmaceutical compound widely used as an antidepressant and anxiolytic.*